Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID)

Newborn bloodspot screening (NBS) for cystic fibrosis (CF) is an effective strategy for the early recognition of infants with a CF diagnosis. Some infants with a positive NBS result for CF have an inconclusive diagnosis and evidence suggests the number of these infants is increasing, as more extensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinha, Aditi, Southern, Kevin W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753618/
https://www.ncbi.nlm.nih.gov/pubmed/35035555
http://dx.doi.org/10.1183/20734735.0088-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753618/
https://www.ncbi.nlm.nih.gov/pubmed/35035555
http://dx.doi.org/10.1183/20734735.0088-2021

Ejemplares similares